Jump to content

Choose locationSutter Amador Hospital
  • Sign in or Enroll
    • Open I want to choose my medical group or hospital
    • Clear my location
Change Location

We've expanded your view

You are now viewing all services in the Sutter Health network. You can change your location above to narrow your view to a medical group, hospital, city or zip.
Sutter Health
  • Video Visits
  • Find Doctors
  • Find Locations
  • Treatments & Services
  • Locations
  • Sign in or Enroll
    • Video Visits
    • Find Doctors
    • Find Locations
    • Treatments & Services
    • COVID-19 Resources
    • Pay a Bill
    • Symptom Checker
    • Get Care Today
    • Diseases & Conditions
    • Health & Wellness
    • Classes & Events
    • Research & Clinical Trials
    • For Patients
    • About Sutter Health
    • Giving
    • Volunteering
    • Careers
    • News
    • For Medical Professionals
    • Other Business Services
Close Search
  • Home
  • Sutter Amador
  • Research
  • Investigators
  • Wei Wang
Content

Investigator Wei Wang, MD

Wei Wang, MD

View profile  

 


Sutter Health Research Enterprise
2100 Webster Street
San Francisco, CA, 94115
(415) 885-8600  
ClinicalResearch@sutterhealth.org

Primary Research Interests

  • Biliary Cancer
  • Cervical Cancer
  • Endometrial Cancer
  • Gastrointestinal Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Skin Cancer/Melanoma
  • Solid Tumors

Related Clinical Trials

Locally Advanced (CheckMate73L)

A Study of Nivolumab and Ipilimumab in Untreated Patients With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

Investigators: Ari Baron M.D., Caroline Behler MD, Kevin Kim MD, Alan Kramer MD, Wei Wang MD

Status: Active, Recruiting

Locally Advanced or Metastatic (Merck 7339-007)

Study of Olaparib in Combination With Pembrolizumab in the Treatment of HRRm and/or HRD Positive Advanced Cancer

Investigators: Lejla Delic MD, Kevin Kim MD, Wei Wang MD

Status: Active, Recruiting

Locally Advanced or Metastatic (Nektar PROPEL)

Study of NKTR-214 in Combination With Pembrolizumab and of NKTR-214 in Combination With Atezolizumab in Patients With Select Advanced or Metastatic Solid Tumors

Investigators: Kevin Kim MD, Wei Wang MD

Status: Active, Recruiting

Locally Advanced or Metastatic (Regeneron R3767)

Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers

Investigators: Kevin Kim MD, Wei Wang MD

The Sutter Health Network of Care
Expertise to fit your needs
Primary Care

Check-ups, screenings and sick visits for adults and children.

Specialty Care

Expertise and advanced technologies in all areas of medicine.

Emergency Care

For serious accidents, injuries and conditions that require immediate medical care.

Urgent Care

After-hours, weekend and holiday services.

Walk-In Care

Convenient walk-in care clinics for your non-urgent health needs.

About Sutter

  • About Our Network
  • Annual Report
  • Awards
  • Community Benefit
  • Contact Us
  • News
  • Giving

    • Find Care

  • Birth Centers
  • Care Centers
  • Emergency Rooms
  • Hospitals
  • Imaging
  • Labs
  • Surgery Centers
  • Urgent Care
  • Walk-In Care
  • View All >

    • Featured Services

  • Behavioral Health
  • Cancer Services
  • Family Medicine
  • Home Health and Hospice
  • Orthopedics
  • Pediatrics
  • Pregnancy
  • Primary Care
  • Women's Health
  • View All >

    • Patient Resources

  • Accepted Health Plans
  • Classes and Events
  • Estimate Costs
  • Flu Resources
  • Health and Wellness
  • Medical Records
  • Medicare
  • My Health Online
  • Pay a Bill
  • Symptom Checker

    • Our Team

  • For Employees
  • Physician Careers
  • Recruiting Events
  • Sutter Careers
  • Vendors
  • Volunteers
    • ADA Accessibility
    • Contact
    • Privacy
    • Do Not Sell My Personal Information

    • LinkedIn Opens new window
    • YouTube Opens new window
    • Facebook Opens new window
    • Twitter Opens new window
    • Glassdoor Opens new window
    • Instagram Opens new window

    Copyright © 2021 Sutter Health. All rights reserved. Sutter Health is a registered trademark of Sutter Health ®, Reg. U.S. Patent & Trademark office.

    Cookie Policy

    We use cookies to give you the best possible user experience. By continuing to use the site, you agree to the use of cookies. Privacy Policy Cookie Preferences

    Privacy Policy Cookie Preferences